تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
A randomized, double-blind, placebo controlled study assessing the long-term effect of dupilumab on prevention of lung function decline in patients with uncontrolled moderate to severe asthma Sanofi Aventis Ongoing Dupilumab 4 LPS16676 King Saud Medical City (Riyadh),King Abdullah Medical City (Makkah)
Transthyretin Amyloidosis Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients With Documented Transthyretin Gene Mutations or Wild-Type Transthyretin Amyloidosis Pfizer Terminated Tafamidis 4 B3461001 King Faisal Specialist Hospital and Research Center (Riyadh)
A single arm, multicentre observational study to evaluate effectiveness of pegcetacoplan under real world conditions in patients with paroxysmal nocturnal hemoglobinuria (PNH) COMPLETE Sobi - Swedish Orphan Biovitrum AG Ongoing pegcetacoplan (ASPAVELI) 4 Sobi.PEGCE King Faisal Specialist Hospital and Research Center (Jeddah),King Faisal Specialist Hospital and Research Center (Riyadh),King Faisal Specialist Hospital and Research Center (Madinah)
The Effect of Black Seeds (Nigella Sativa) on Prediabetic Overweight and Obese Adolescents Imam Abdulrhman bin Faisal university Ongoing Nigella sativa seeds 3 2230500005 Family and Community Medicine Center (Dammam)
VICTORION REAL: An international prospective Real-world study to evaluate the Effectiveness and Adherence of incLisiran plus standard of care lipid-lowering therapy compared to standard of care therapy alone in patients with primary hypercholesterolemia or mixed dyslipidemia Novartis Ongoing Inclisiran 4 CKJX839A12 Saud Al-Babtain Cardiac Center (Dammam) , King Salman Armed Forces Hospital(Tabuk) , King Fahd Armed Forces Hospital (Jeddah) , Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh),King Faisal Specialist Hospital and Research Center (Jeddah), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), International Medical Center (Jeddah)
A Randomized, Double Blinded, Comparative Observational Interventional Study to Assess The Safety And Immunogenicity Of Hepatitis B Vaccine In Newborns / Adolescents And Adults Six Months Post Vaccination Arab Company for Pharmaceutical products Ongoing EUVAX B VACCINE 4 HBV-001 King Fahad Medical City (Riyadh)
Impact of using Zinc Oxide versus Moist Exposed Wound Ointment (MEBO) in treatment of second stage pressure ulcer: A randomized control clinical trial King Abdullah Medical City (Makkah) Ongoing MEBO and Zinc oxide topical 3 Version 5 King Abdullah Medical City (Makkah)
A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP) CLINUVEL EUROPE LIMITED Ongoing Afamelanotide 2a CUV156 King Faisal Specialist Hospital and Research Center (Riyadh)
A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib Novartis Ongoing remibrutinib 3 CLOU064C123 King Faisal Specialist Hospital and Research Center (Jeddah) - King Abdulaziz Medical City NG (Jeddah) - King Abdulaziz Medical City NG (Riyadh)
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II KalVista Pharmaceuticals Ltd Ongoing Sebetralstat 3 KVD900-302 King Faisal Specialist Hospital and Research Center (Riyadh)
عرض 31 - 40 من 421